Skip to main content
Erschienen in: BMC Pregnancy and Childbirth 1/2020

Open Access 01.12.2020 | Research article

A condom uterine balloon device among referral facilities in Dar Es Salaam: an assessment of perceptions, barriers and facilitators one year after implementation

verfasst von: Oluwakemi Adegoke, Sandra Danso-Bamfo, Margaret Sheehy, Vincent Tarimo, Thomas F. Burke, Lorraine F. Garg

Erschienen in: BMC Pregnancy and Childbirth | Ausgabe 1/2020

Abstract

Background

Postpartum hemorrhage (PPH) is the leading cause of maternal death in Tanzania. The Every Second Matters for Mothers and Babies- Uterine Balloon Tamponade (ESM-UBT) device was developed to address this problem in women with atonic uterus. The objective of this study was to understand the barriers and facilitators to optimal use of the device, in Dar es Salaam Tanzania 1 year after implementation.

Methods

Semi-structured interviews of skilled-birth attendants were conducted between May and July 2017. Interviews were recorded, coded and analyzed for emergent themes.

Results

Among the participants, overall there was a positive perception of the ESM-UBT device. More than half of participants reported the device was readily available and more than 1/3 described ease and success with initial use. Barriers included fear and lack of refresher training. Finally, participants expressed a need for training and device availability at peripheral hospitals.

Conclusion

The implementation and progression to optimal use of the ESM-UBT device in Tanzania is quite complex. Ease of use and the prospect of saving a life/preserving fertility strongly promoted use while fear and lack of high-level buy-in hindered utilization of the device. A thorough understanding and investigation of these facilitators and barriers are required to increase uptake of the ESM-UBT device.
Hinweise

Supplementary information

Supplementary information accompanies this paper at https://​doi.​org/​10.​1186/​s12884-020-2721-9.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
ESM-UBT
Every Second Matters for Mothers and Babies- Uterine Balloon Tamponade (ESM-UBT)
PPH
Postpartum hemorrhage

Background

Nearly 300,000 women die annually during pregnancy with postpartum hemorrhage (PPH) the leading cause worldwide [1]. Ninety-nine percent of these deaths occur in low-income countries [2]. In Tanzania, the maternal mortality ratio is 398 per 100,000 live births with hemorrhage and hypertensive disorders accounting for most of these deaths [3]. Although there are several risk factors for postpartum hemorrhage such as high parity, multiple gestations, polyhydramnios, prolonged and augmented labor, and pre-eclampsia [4] the majority of cases of PPH are unpredictable [5].
Uterotonics are recommended in the initial management of PPH. However, if hemorrhage is refractory to uterotonic agents, uterine balloon tamponade and surgical interventions such as uterine artery ligation, compression sutures, and/or hysterectomy may be employed [6]. Uterine balloon tamponade is non-invasive and appears able to avert the need for surgical intervention in the majority of women with uncontrolled PPH from atonic uterus [710]. In a systematic review, Tindell et al. reported that in the thirteen studies UBT effectively controlled postpartum hemorrhage in 234 of 241 cases, with average resolution of hemorrhage in 4 to 15 min. Complication rates were low in the use of all types of UBT, with no reported cases of uterine rupture and no increased risk of infection [10].
Since commercially available uterine balloon tamponade devices are expensive and often not available in low resource settings [11], the Division of Global Health and Innovation at the Massachusetts General Hospital developed an ultra-low-cost uterine balloon tamponade device known as Every Second Matters for Mothers and Babies- Uterine Balloon Tamponade (ESM-UBT). The ESM-UBT package consists of the ESM-UBT device, a PPH clinical management pathway, and a training module (Table 1). Over the past 10 years, the ESM-UBT device has been implemented in collaboration with in-country partners across more than 14 countries [12, 13], including four referral hospitals in Dar es Salaam, Tanzania. Prior research demonstrated that in this setting, women with uncontrolled PPH from atonic uterus who had ESM-UBT devices placed, survived 97% of the time overall and nearly 100% of the time when placed before advanced shock [14].
Table 1
ESM-UBT training curriculum
• Contents of device: syringe with a Luer lock valve, condom, Foley catheter with cotton string
• Training and curriculum materials: PPH-UBT job aid checklist, a wall poster, PPH clinical pathway guide, a trainer’s flipchart, and a learner’s booklet
• Trainees were instructed to use the UBT within the context of the established national protocol for PPH, which first included active management of the third stage of labor:
• uterine massage
• emptying the bladder
• breastfeeding (if feasible)
• identifying and treating perineal or cervical tears
• administering prophylactic oxytocin and/or misoprostol (or other uterotonics if available)
• manual removal of the placenta and blood clots
• placement of the uterine balloon should occur if these interventions fail
• Training-of-trainers model: the training program was a participatory, skills-based training that used hands-on PPH scenarios and simple maternal uterine models made of local components (e.g. a pillow surrounding a plastic water bottle, which represented a uterus within an abdomen)
• Trainees were representative maternal health providers from each facility and were brought to a regional location for initial training.
• These providers then returned to their facilities and trained staff with the target of ensuring that at least 85% of maternity providers in each facility achieved competence in UBT placement (defined as ‘online’ status).
• All facilities received one wall chart checklist per delivery room, two manuals for PPH management and UBT use, and an adequate number of pre-deviced ESM-UBT kits (i.e. device and checklist).
While the ESM-UBT device is both low cost and efficacious [1315], changing health care provider behavior can be complex and challenging [1620]. There is, however, a growing body of literature that seeks to identify implementation approaches that drive optimal provider performance and quality overall care [16, 1822]. Tailoring interventions to address known determinants of practice has been shown to influence health care provider practice [2326] and a number of authors have emphasized the importance of identifying barriers in order to strengthen implementation efforts [16, 17, 26, 27]. Given the challenges with changing health care provider practice patterns and the potential benefit of tailored interventions, it is important to identify those factors that lead to and impede uptake of the ESM-UBT device in order to adequately address them during implementation efforts. This study, which involved interviewing OBGYNs and skilled birth attendants 1 year after ESM-UBT was implemented at their hospitals in Dar es Salaam, Tanzania, was conducted to better understand facilitators and barriers to ESM-UBT device uptake and provider perceptions.

Methods

All staff that attended births, including OBGYN specialists, nurses, midwives, physician assistants and non-specialist physicians, were invited to attend initial ESM-UBT trainings beginning in March 2016, across four hospitals in Dar Es Salaam, Tanzania. During that calendar year, these four hospitals performed a total of 46,072 deliveries. Trainings involved reviewing causes of postpartum hemorrhage, uterotonics, and treatment of postpartum hemorrhage, focusing primarily on the setup and utilization of the ESM-UBT device (Table 1). Facilities were officially ‘online’ when 85% of their staff had been trained. At least two refresher in-service trainings were also held at each facility. Following the trainings, use of the ESM-UBT device was considered standard practice for uncontrolled PPH from atonic uterus at the participating referral hospitals. A total of 29 OBGYN specialists, 141 medical officers and 297 midwives/nurses were trained on the ESM-UBT device through 22 training sessions.
In May and June of 2017, two external physician researchers (MS and OA) conducted semi-structured interviews of obstetrician-gynecologists, nurse-midwives, medical officers and post-graduate doctors employed at two of the four online hospitals (one tertiary and one district hospital). Providers were eligible for interview if they had participated in at least one ESM-UBT training module and had managed at least one case of uncontrolled PPH since that training. Convenience sampling of staff who satisfied inclusion criteria was employed due to the participants’ work schedules. All current staff who satisfied the inclusion criteria were then contacted by phone to determine their availability for an in-person interview. Verbal informed consent was obtained from participants prior to beginning the interviews. The researchers obtained phone numbers of individuals currently working at the two hospitals and contacted each person to determine if they were available for an interview. Interviews were audio recorded and transcribed verbatim. Investigators interviewed providers from diverse training backgrounds until thematic saturation was reached. Three researchers (OA, MA, SDB) independently coded the interview transcripts, reconciled any differences in coding, and identified themes that emerged from the interviews. A data codebook (Additional file 1) was created by author consensus through an iterative process. Data were coded using NVivo 11 (QSR International, Doncaster, VIC, Australia).

Results

Twenty-five health workers were interviewed, nine of which were from Amana District Hospital and sixteen from Muhimbili National Hospital. Twelve of the interviewees were nurse midwives, six OBGYNS, six postgraduate doctors, and one a general practitioner. Nine were male and sixteen females. Ages ranged from 26 to 50 years. Sixteen (64%) of the interviewed health care workers reported greater than 5 years of experience. Several themes emerged and are described below:

Perceptions and attitudes

All participants reported positive attitudes toward the ESM-UBT device while 13 additionally reported that their colleagues had positive things to say about the ESM-UBT device. A minority of doctors (three) stated their colleagues expressed a need for more education or “convincing” regarding the utility of the ESM-UBT device. All providers from both facilities reported that patient perceptions of the ESM-UBT device were overwhelmingly positive. Seven providers described fear as a barrier to UBT use. They feared being blamed for incorrect identification of the cause of hemorrhage and that placement of an ESM-UBT device could contribute to a delay in definitive intervention such as hysterectomy. They also expressed concern that they could be penalized for performing an intervention (UBT) about which their supervising consultants were unfamiliar. Two obstetricians described that hemorrhaging women were commonly transferred from other facilities in critical condition. They believed that this urgent situation may have led providers to perform procedures that they were more accustomed to and comfortable with such as supra-cervical hysterectomies. In addition, two OBGYN postgraduates stated that some supervising senior OBGYNs were resistant to ‘new’ conservative management modalities and appeared less interested than other providers in the ESM-UBT trainings.

ESM-UBT device

Nearly one-third of those interviewed described that the ESM-UBT device was easy to use. One doctor mentioned that it was a simpler and quicker procedure than a hysterectomy while other interviewed providers reported they did not find it difficult to use the ESM-UBT device after the initial training. One provider stated that the time required to set up the ESM-UBT device was too long and suggested that a pre-assembled device might be easier to use.

Training and knowledge

More than half the respondents stated they first heard about the ESM-UBT device during the initial training session and that the training program facilitated use in hemorrhaging women. Four midwives felt more comfortable using an ESM-UBT device after completing a refresher training. Some providers reported learning about the ESM-UBT device through word of mouth and during shifts at the hospital with other employees.
Several individuals described the need for regular refresher trainings for all OBGYN staff. Several midwives stated that doctors (postgraduates and MOs) are often posted to the OBGYN service and labor wards and then rotate; hence the need for recurrent trainings. Finally, a few providers mentioned that there was a dearth of staff to assist with PPH management hence instructing (untrained) personnel on the setup of the ESM-UBT device at the time of hemorrhage was sometimes stressful.
The most frequently reported barrier to ESM-UBT use was lack of knowledge on how to use the device; either because the provider had never been trained, was trained several months prior or had never seen an ESM-UBT device used. A few providers mentioned that they did not know how much fluid to instill into the ESM-UBT device and thus hesitated to use it. A small number of providers mentioned that they witnessed a UBT device placed in patients with cervical tears without uterine atony.

ESM-UBT access/availability

Most health care workers stated that ESM-UBT devices were located on the labor or post-natal wards in labeled PPH kits that contain medications and devices commonly used to manage postpartum hemorrhage. Nearly half of the providers stated that ESM-UBT devices were readily available when needed and most reported they knew the exact location. A few providers described that in their experience ESM-UBT kits were not available on the labor ward or in the operating theatre when needed. All the interviewed providers stated that they could obtain ESM-UBT devices from other wards when necessary.

Effect of prior experience

More than half of the providers described positive experiences with an ESM-UBT device, and several providers stated that they were more likely to use the ESM-UBT device after hearing about previous successes from other colleagues. Two providers reported they felt more comfortable using an ESM-UBT device when an individual who had prior experience with the device was working with them.

Expansion of ESM-UBT availability

Another theme that emerged was the need for ESM-UBT training and device availability at peripheral hospitals. Several providers described that since ambulance services and blood products are scarce, hemorrhaging women often arrive at referral facilities too late to save them. Most individuals stated that expansion of the ESM-UBT program to lower levels of care would reduce morbidity and mortality.

ESM-UBT adoption and uptake

A few individuals stated that their desire to save a life with an ESM-UBT device was a motivating factor. Approximately one third of providers described that the ability to potentially preserve a patient’s fertility and uterus was motivating. Nevertheless, the desire to gain surgical experience was mentioned as a potential reason for lower than expected rates of UBT adoption.

Discussion

Postpartum hemorrhage continues to be a leading cause of maternal mortality worldwide with low-income countries disproportionately affected. Overall, 1 year after the introduction of the ESM-UBT device, the ESM-UBT device was perceived by all cadres as easy to use, accessible, and effective in saving lives. However similar to prior research in Sierra Leone, Senegal and Kenya several barriers to optimal uptake remain [28].
Several factors were identified that appeared to facilitate UBT use; perhaps one of the most important being the role of training. Given the nature of frequent provider turnover, regularly scheduled in-service trainings should be offered on a frequent basis. Pre-service training also represents a valuable opportunity to introduce UBT during the formative stages of a health care provider’s career. In addition, refresher trainings offer a way to ensure that providers remain knowledgeable and comfortable with use of the UBT device. This is especially important in lower volume facilities where uncontrolled postpartum hemorrhage may be seen less frequently. These findings are similar to previous studies regarding advanced structured resuscitation trainings such as Advanced Cardiac Life Support (ACLS) and Neonatal Resuscitation Program (NRP). Research has demonstrated that simulation-based interventions along with refresher courses had the greatest impact on skills retention [29]. Low-cost simulation and training have also been shown to be effective in low resource settings in the management of PPH [3032] as well as other emergencies [33].
The interviews provided insights into factors that might motivate providers to use ESM-UBT devices; such as sense that the device might save a mother’s life or preserve a woman’s uterus. A similar sentiment was noted by Pendleton et al. in regard to health care providers’ motivation to use ESM-UBT devices in Kenya and Senegal [34]. The message that ESM-UBT devices may save mothers’ lives and avert hysterectomies should be highlighted in trainings and elsewhere.
Sharing UBT success stories may increase ESM-UBT device uptake given that providers reported increased comfort with the use after hearing about their colleagues’ previous successes. Potential avenues for sharing experiences include simple word of mouth as well as more formal settings such as lectures and hospital morning reports. Since providers expressed increased comfort with use of ESM-UBT devices when a colleague with previous ESM-UBT experience was present at the time of insertion, it may be beneficial to train additional providers from all cadres and establish mentorship programs/teams. In-country champions could also be utilized to provide encouragement and support as well as mentorship. Previous research has demonstrated the importance of ongoing dissemination of the findings to various actors in different levels of the health care system in order to ensure and maintain stakeholder buy-in for health programs in rural cities [21].
Expansion of UBT training and device availability at peripheral hospitals was an important factor that could facilitate use of UBT devices at these facilities and potentially contribute to decreases in morbidity and mortality. Given the lack of blood and surgical capabilities at many lower level hospitals as well as delays that often occur during the transfer process, use of UBT devices prior to transfer has the potential to reduce morbidity and mortality in women with uncontrolled PPH.
Several barriers to ESM-UBT use were identified. The finding that residents and medical officers at times feared anger and reprimand from senior physicians for using an ESM-UBT device highlights the need to enlist senior OBGYNs as champions. These senior-level OBGYN champions can address their colleagues’ resistance to change as well as enable provider fears to be directly discussed. As demonstrated in similar studies, local leadership is key in implementing interventions and the potential adaptation and scale up of programs and devices [35]. This may be critical in helping to alleviate the fear of possible retribution of senior health care providers. Lack of knowledge was another prominent barrier to ESM-UBT use. This lack of knowledge as well as waning of knowledge has the potential to impact the appropriate use of the device. Training all cadres of providers that attend deliveries to use UBT could ensure that more people in a facility are trained and therefore able to provide mentorship and support for UBT use during a PPH emergency.
Another described barrier was that ESM-UBT kits were not always available when needed. Ensuring that UBT devices are easily available and accessible at the time of an obstetrical emergency is essential as delays from trying to locate a kit may discourage use and could potentially impact hemorrhaging patients’ outcomes. As with previous studies, champions and/or specific PPH teams could address training needs as well as work with hospital staff to ensure availability and accessibility of UBT devices [35].
Our study findings are limited by our convenience sampling methodology and the potential for a desirability bias. Due to logistical constraints and staff scheduling, providers were recruited only if they met inclusion criteria and were willing and able to participate during the two-week interview period. An inherent and socio-culturally buttressed desire to not cause offence, particularly to those who are foreign and connected to the implementation of the intervention being studied, could have led to increased positive remarks. However, this seems unlikely to have introduced a significant bias as a broad range of perceptions were captured. Another potential limitation may stem from only conducting interviews at two hospitals, the National Referral Hospital and a smaller facility. This may have introduced a significant limitation as the patient populations and work environment of the facilities differ from one another.

Conclusion

This study adds to the growing body of evidence that introduction and achievement of optimal uptake of new interventions, such as UBT, is complex. Facilitators to optimal use of the ESM-UBT device included formal training, refresher training, sharing success stories, and mentorship. Barriers included fear, lack of knowledge, inadequate supply, and fixed practice habits among senior doctors. As the ESM-UBT device is scaled, these factors should be incorporated into implementation strategies.

Supplementary information

Supplementary information accompanies this paper at https://​doi.​org/​10.​1186/​s12884-020-2721-9.

Acknowledgements

The authors would like to thank the Ujenzi Charitable Trust and Every Mother Counts Trust for providing unrestricted funding. We especially thank all the midwives and physicians who gave of their time to help make this research possible.
This study was approved by Partners Human Research Committee, the Institutional Review Board of Partners HealthCare (Boston, MA, USA), and the National Institute for Medical Research (Dar es Salaam, Tanzania). The Institutional Review Board and the National Institute for Medical Research approved the use of verbal informed consent. Verbal consent was sought at the beginning of each interview. If consent was granted it was documented using a digital audio recorder.
Not applicable.

Competing interests

The authors whose names are listed on the first page of the manuscript have reviewed and approved this manuscript and certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
2.
Zurück zum Zitat Say L, Chou D, Gemmill A, Tuncalp O, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323–33.CrossRef Say L, Chou D, Gemmill A, Tuncalp O, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323–33.CrossRef
3.
Zurück zum Zitat Afnan-Holmes H, Magoma M, John T, Levira F, Msemo G, Armstrong CE, et al. Tanzania's countdown to 2015: an analysis of two decades of progress and gaps for reproductive, maternal, newborn, and child health, to inform priorities for post-2015. Lancet Glob Health. 2015;3(7):e396–409.CrossRef Afnan-Holmes H, Magoma M, John T, Levira F, Msemo G, Armstrong CE, et al. Tanzania's countdown to 2015: an analysis of two decades of progress and gaps for reproductive, maternal, newborn, and child health, to inform priorities for post-2015. Lancet Glob Health. 2015;3(7):e396–409.CrossRef
4.
Zurück zum Zitat Wetta LA, Szychowski JM, Seals S, Mancuso MS, Biggio JR, Tita AT. Risk factors for uterine atony/postpartum hemorrhage requiring treatment after vaginal delivery. Am J Obstet Gynecol. 2013;209(1):51.e1–6.CrossRef Wetta LA, Szychowski JM, Seals S, Mancuso MS, Biggio JR, Tita AT. Risk factors for uterine atony/postpartum hemorrhage requiring treatment after vaginal delivery. Am J Obstet Gynecol. 2013;209(1):51.e1–6.CrossRef
5.
Zurück zum Zitat Buzaglo N, Harlev A, Sergienko R, Sheiner E. Risk factors for early postpartum hemorrhage (PPH) in the first vaginal delivery, and obstetrical outcomes in subsequent pregnancy. J Matern Fetal Neonatal Med. 2015;28(8):932–7.CrossRef Buzaglo N, Harlev A, Sergienko R, Sheiner E. Risk factors for early postpartum hemorrhage (PPH) in the first vaginal delivery, and obstetrical outcomes in subsequent pregnancy. J Matern Fetal Neonatal Med. 2015;28(8):932–7.CrossRef
6.
Zurück zum Zitat No PB. 183: Postpartum Hemorrhage. Obstet Gynecol. 2017;130(4):e168–e86.CrossRef No PB. 183: Postpartum Hemorrhage. Obstet Gynecol. 2017;130(4):e168–e86.CrossRef
7.
Zurück zum Zitat Patrick R, Poissy Saint-Germain Hospital O, Gynecology PF, Mathilde R, Versailles Saint Quentin University EAM-L-BF, Jonathan C, et al. 530: Intrauterine balloon tamponade (IUBT) for management of severe postpartum hemorrhage (PPH) within a perinatal network: efficacy and factors predicting failure. Am J Obstet Gynecol. 2015;212(1):S265. Patrick R, Poissy Saint-Germain Hospital O, Gynecology PF, Mathilde R, Versailles Saint Quentin University EAM-L-BF, Jonathan C, et al. 530: Intrauterine balloon tamponade (IUBT) for management of severe postpartum hemorrhage (PPH) within a perinatal network: efficacy and factors predicting failure. Am J Obstet Gynecol. 2015;212(1):S265.
8.
Zurück zum Zitat Revert M, Cottenet J, Raynal P, Cibot E, Quantin C, Rozenberg P. Intrauterine balloon tamponade for management of severe postpartum haemorrhage in a perinatal network: a prospective cohort study. BJOG. 2017;124(8):1255–62.CrossRef Revert M, Cottenet J, Raynal P, Cibot E, Quantin C, Rozenberg P. Intrauterine balloon tamponade for management of severe postpartum haemorrhage in a perinatal network: a prospective cohort study. BJOG. 2017;124(8):1255–62.CrossRef
9.
Zurück zum Zitat Revert M, Rozenberg P, Cottenet J, Quantin C. Intrauterine balloon Tamponade for severe postpartum hemorrhage. Obstet Gynecol. 2018;131(1):143–9.PubMed Revert M, Rozenberg P, Cottenet J, Quantin C. Intrauterine balloon Tamponade for severe postpartum hemorrhage. Obstet Gynecol. 2018;131(1):143–9.PubMed
10.
Zurück zum Zitat Tindell K, Garfinkel R, Abu-Haydar E, Ahn R, Burke TF, Conn K, et al. Uterine balloon tamponade for the treatment of postpartum haemorrhage in resource-poor settings: a systematic review. BJOG. 2013;120(1):5–14.CrossRef Tindell K, Garfinkel R, Abu-Haydar E, Ahn R, Burke TF, Conn K, et al. Uterine balloon tamponade for the treatment of postpartum haemorrhage in resource-poor settings: a systematic review. BJOG. 2013;120(1):5–14.CrossRef
12.
Zurück zum Zitat Nelson BD, Stoklosa H, Ahn R, Eckardt MJ, Walton EK, Burke TF. Use of uterine balloon tamponade for control of postpartum hemorrhage by community-based health providers in South Sudan. Int J Gynaecol Obstet. 2013;122(1):27–32.CrossRef Nelson BD, Stoklosa H, Ahn R, Eckardt MJ, Walton EK, Burke TF. Use of uterine balloon tamponade for control of postpartum hemorrhage by community-based health providers in South Sudan. Int J Gynaecol Obstet. 2013;122(1):27–32.CrossRef
13.
Zurück zum Zitat Burke TF, Ahn R, Nelson BD, Hines R, Kamara J, Oguttu M, et al. A postpartum haemorrhage package with condom uterine balloon tamponade: a prospective multi-Centre case series in Kenya, Sierra Leone, Senegal, and Nepal. BJOG. 2016;123(9):1532–40.CrossRef Burke TF, Ahn R, Nelson BD, Hines R, Kamara J, Oguttu M, et al. A postpartum haemorrhage package with condom uterine balloon tamponade: a prospective multi-Centre case series in Kenya, Sierra Leone, Senegal, and Nepal. BJOG. 2016;123(9):1532–40.CrossRef
14.
Zurück zum Zitat Burke TF, Danso-Bamfo S, Guha M, Oguttu M, Tarimo V, Nelson BD. Shock progression and survival after use of a condom uterine balloon tamponade package in women with uncontrolled postpartum hemorrhage. Int J Gynaecol Obstet. 2017;139(1):34–8.CrossRef Burke TF, Danso-Bamfo S, Guha M, Oguttu M, Tarimo V, Nelson BD. Shock progression and survival after use of a condom uterine balloon tamponade package in women with uncontrolled postpartum hemorrhage. Int J Gynaecol Obstet. 2017;139(1):34–8.CrossRef
15.
Zurück zum Zitat Mvundura M, Kokonya D, Abu-Haydar E, Okoth E, Herrick T, Mukabi J, et al. Cost-effectiveness of condom uterine balloon tamponade to control severe postpartum hemorrhage in Kenya. Int J Gynaecol Obstet. 2017;137(2):185–91.CrossRef Mvundura M, Kokonya D, Abu-Haydar E, Okoth E, Herrick T, Mukabi J, et al. Cost-effectiveness of condom uterine balloon tamponade to control severe postpartum hemorrhage in Kenya. Int J Gynaecol Obstet. 2017;137(2):185–91.CrossRef
16.
Zurück zum Zitat Fischer F, Lange K, Klose K, Greiner W, Kraemer A. Barriers and Strategies in Guideline Implementation-A Scoping Review. Healthcare (Basel). 2016;4(3):1–34.CrossRef Fischer F, Lange K, Klose K, Greiner W, Kraemer A. Barriers and Strategies in Guideline Implementation-A Scoping Review. Healthcare (Basel). 2016;4(3):1–34.CrossRef
17.
Zurück zum Zitat Puchalski Ritchie LM, Khan S, Moore JE, Timmings C, van Lettow M, Vogel JP, et al. Low- and middle-income countries face many common barriers to implementation of maternal health evidence products. J Clin Epidemiol. 2016;76:229–37.CrossRef Puchalski Ritchie LM, Khan S, Moore JE, Timmings C, van Lettow M, Vogel JP, et al. Low- and middle-income countries face many common barriers to implementation of maternal health evidence products. J Clin Epidemiol. 2016;76:229–37.CrossRef
18.
Zurück zum Zitat Rowe AK, Rowe SY, Peters DH, Holloway KA, Chalker J, Ross-Degnan D. Effectiveness of strategies to improve health-care provider practices in low-income and middle-income countries: a systematic review. Lancet Glob Health. 2018;6(11):e1163–e75.CrossRef Rowe AK, Rowe SY, Peters DH, Holloway KA, Chalker J, Ross-Degnan D. Effectiveness of strategies to improve health-care provider practices in low-income and middle-income countries: a systematic review. Lancet Glob Health. 2018;6(11):e1163–e75.CrossRef
19.
Zurück zum Zitat Siddiqi K, Newell J, Robinson M. Getting evidence into practice: what works in developing countries? Int J Qual Health Care. 2005;17(5):447–54.CrossRef Siddiqi K, Newell J, Robinson M. Getting evidence into practice: what works in developing countries? Int J Qual Health Care. 2005;17(5):447–54.CrossRef
20.
Zurück zum Zitat Siddiqi K, Newell JN. Putting evidence into practice in low-resource settings. Bull World Health Organ. 2005;83(12):882.PubMed Siddiqi K, Newell JN. Putting evidence into practice in low-resource settings. Bull World Health Organ. 2005;83(12):882.PubMed
21.
Zurück zum Zitat Althabe F, Chomba E, Tshefu AK, Banda E, Belizan M, Bergel E, et al. A multifaceted intervention to improve syphilis screening and treatment in pregnant women in Kinshasa, Democratic Republic of the Congo and in Lusaka, Zambia: a cluster randomised controlled trial. Lancet Glob Health. 2019;7(5):e655–e63.CrossRef Althabe F, Chomba E, Tshefu AK, Banda E, Belizan M, Bergel E, et al. A multifaceted intervention to improve syphilis screening and treatment in pregnant women in Kinshasa, Democratic Republic of the Congo and in Lusaka, Zambia: a cluster randomised controlled trial. Lancet Glob Health. 2019;7(5):e655–e63.CrossRef
22.
Zurück zum Zitat Bergstrom A, Skeen S, Duc DM, Blandon EZ, Estabrooks C, Gustavsson P, et al. Health system context and implementation of evidence-based practices-development and validation of the context assessment for community health (COACH) tool for low- and middle-income settings. Implement Sci. 2015;10:120.CrossRef Bergstrom A, Skeen S, Duc DM, Blandon EZ, Estabrooks C, Gustavsson P, et al. Health system context and implementation of evidence-based practices-development and validation of the context assessment for community health (COACH) tool for low- and middle-income settings. Implement Sci. 2015;10:120.CrossRef
23.
Zurück zum Zitat Baker R, Camosso-Stefinovic J, Gillies C, Shaw EJ, Cheater F, Flottorp S, et al. Tailored interventions to address determinants of practice. Cochrane Database Syst Rev. 2015;4:CD005470. Baker R, Camosso-Stefinovic J, Gillies C, Shaw EJ, Cheater F, Flottorp S, et al. Tailored interventions to address determinants of practice. Cochrane Database Syst Rev. 2015;4:CD005470.
24.
Zurück zum Zitat Cahill NE, Murch L, Cook D, Heyland DK. Canadian critical care trials G. improving the provision of enteral nutrition in the intensive care unit: a description of a multifaceted intervention tailored to overcome local barriers. Nutr Clin Pract. 2014;29(1):110–7.CrossRef Cahill NE, Murch L, Cook D, Heyland DK. Canadian critical care trials G. improving the provision of enteral nutrition in the intensive care unit: a description of a multifaceted intervention tailored to overcome local barriers. Nutr Clin Pract. 2014;29(1):110–7.CrossRef
25.
Zurück zum Zitat Garcia-Elorrio E, Rowe SY, Teijeiro ME, Ciapponi A, Rowe AK. The effectiveness of the quality improvement collaborative strategy in low- and middle-income countries: a systematic review and meta-analysis. PLoS One. 2019;14(10):e0221919.CrossRef Garcia-Elorrio E, Rowe SY, Teijeiro ME, Ciapponi A, Rowe AK. The effectiveness of the quality improvement collaborative strategy in low- and middle-income countries: a systematic review and meta-analysis. PLoS One. 2019;14(10):e0221919.CrossRef
26.
Zurück zum Zitat Joosen MCW, van Beurden KM, Rebergen DS, Loo M, Terluin B, van Weeghel J, et al. Effectiveness of a tailored implementation strategy to improve adherence to a guideline on mental health problems in occupational health care. BMC Health Serv Res. 2019;19(1):281.CrossRef Joosen MCW, van Beurden KM, Rebergen DS, Loo M, Terluin B, van Weeghel J, et al. Effectiveness of a tailored implementation strategy to improve adherence to a guideline on mental health problems in occupational health care. BMC Health Serv Res. 2019;19(1):281.CrossRef
27.
Zurück zum Zitat Shayan SJ, Kiwanuka F, Nakaye Z. Barriers associated with evidence-based practice among nurses in low- and middle-income countries: a systematic review. Worldviews Evid-Based Nurs. 2019;16(1):12–20.CrossRef Shayan SJ, Kiwanuka F, Nakaye Z. Barriers associated with evidence-based practice among nurses in low- and middle-income countries: a systematic review. Worldviews Evid-Based Nurs. 2019;16(1):12–20.CrossRef
28.
Zurück zum Zitat Natarajan A, Kamara J, Ahn R, Nelson BD, Eckardt MJ, Williams AM, et al. Provider experience of uterine balloon tamponade for the management of postpartum hemorrhage in Sierra Leone. Int J Gynaecol Obstet. 2016;134(1):83–6.CrossRef Natarajan A, Kamara J, Ahn R, Nelson BD, Eckardt MJ, Williams AM, et al. Provider experience of uterine balloon tamponade for the management of postpartum hemorrhage in Sierra Leone. Int J Gynaecol Obstet. 2016;134(1):83–6.CrossRef
29.
Zurück zum Zitat Au K, Lam D, Garg N, Chau A, Dzwonek A, Walker B, et al. Improving skills retention after advanced structured resuscitation training: a systematic review of randomized controlled trials. Resuscitation. 2019;138:284–96.CrossRef Au K, Lam D, Garg N, Chau A, Dzwonek A, Walker B, et al. Improving skills retention after advanced structured resuscitation training: a systematic review of randomized controlled trials. Resuscitation. 2019;138:284–96.CrossRef
30.
Zurück zum Zitat Egenberg S, Masenga G, Bru LE, Eggebo TM, Mushi C, Massay D, et al. Impact of multi-professional, scenario-based training on postpartum hemorrhage in Tanzania: a quasi-experimental, pre- vs. post-intervention study. BMC Pregnancy Childbirth. 2017;17(1):287.CrossRef Egenberg S, Masenga G, Bru LE, Eggebo TM, Mushi C, Massay D, et al. Impact of multi-professional, scenario-based training on postpartum hemorrhage in Tanzania: a quasi-experimental, pre- vs. post-intervention study. BMC Pregnancy Childbirth. 2017;17(1):287.CrossRef
31.
Zurück zum Zitat Nelissen E, Ersdal H, Mduma E, Evjen-Olsen B, Twisk J, Broerse J, et al. Clinical performance and patient outcome after simulation-based training in prevention and management of postpartum haemorrhage: an educational intervention study in a low-resource setting. BMC Pregnancy Childbirth. 2017;17(1):301.CrossRef Nelissen E, Ersdal H, Mduma E, Evjen-Olsen B, Twisk J, Broerse J, et al. Clinical performance and patient outcome after simulation-based training in prevention and management of postpartum haemorrhage: an educational intervention study in a low-resource setting. BMC Pregnancy Childbirth. 2017;17(1):301.CrossRef
32.
Zurück zum Zitat Perosky J, Richter R, Rybak O, Gans-Larty F, Mensah MA, Danquah A, et al. A low-cost simulator for learning to manage postpartum hemorrhage in rural Africa. Simul Healthc. 2011;6(1):42–7.CrossRef Perosky J, Richter R, Rybak O, Gans-Larty F, Mensah MA, Danquah A, et al. A low-cost simulator for learning to manage postpartum hemorrhage in rural Africa. Simul Healthc. 2011;6(1):42–7.CrossRef
33.
Zurück zum Zitat Mwandri M, Walsh M, Frantz J, Delport R. The use of low-cost simulation in a resource-constrained teaching environment; 2017.CrossRef Mwandri M, Walsh M, Frantz J, Delport R. The use of low-cost simulation in a resource-constrained teaching environment; 2017.CrossRef
34.
Zurück zum Zitat Pendleton AA, Natarajan A, Ahn R, Nelson BD, Eckardt MJ, Burke TF. A qualitative assessment of the impact of a uterine balloon tamponade package on decisions regarding the role of emergency hysterectomy in women with uncontrolled postpartum haemorrhage in Kenya and Senegal. BMJ Open. 2016;6(1):e010083.CrossRef Pendleton AA, Natarajan A, Ahn R, Nelson BD, Eckardt MJ, Burke TF. A qualitative assessment of the impact of a uterine balloon tamponade package on decisions regarding the role of emergency hysterectomy in women with uncontrolled postpartum haemorrhage in Kenya and Senegal. BMJ Open. 2016;6(1):e010083.CrossRef
35.
Zurück zum Zitat Paina L, Namazzi G, Tetui M, Mayora C, Kananura RM, Kiwanuka SN, et al. Applying the model of diffusion of innovations to understand facilitators for the implementation of maternal and neonatal health programmes in rural Uganda. Glob Health. 2019;15(1):38.CrossRef Paina L, Namazzi G, Tetui M, Mayora C, Kananura RM, Kiwanuka SN, et al. Applying the model of diffusion of innovations to understand facilitators for the implementation of maternal and neonatal health programmes in rural Uganda. Glob Health. 2019;15(1):38.CrossRef
Metadaten
Titel
A condom uterine balloon device among referral facilities in Dar Es Salaam: an assessment of perceptions, barriers and facilitators one year after implementation
verfasst von
Oluwakemi Adegoke
Sandra Danso-Bamfo
Margaret Sheehy
Vincent Tarimo
Thomas F. Burke
Lorraine F. Garg
Publikationsdatum
01.12.2020
Verlag
BioMed Central
Erschienen in
BMC Pregnancy and Childbirth / Ausgabe 1/2020
Elektronische ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-020-2721-9

Weitere Artikel der Ausgabe 1/2020

BMC Pregnancy and Childbirth 1/2020 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.